SkinHealth Systems Inc. (NASDAQ: SKIN) Stock Competitors & Peer Comparison
See SKIN's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SKIN and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SKIN | $0.63 | +1.43% | 81.6M | -2.86 | -$0.22 | N/A |
| ALC | $64.75 | -1.05% | 31.6B | 20.36 | $3.18 | +0.55% |
| STE | $210.01 | -0.30% | 20.5B | 20.17 | $10.42 | +1.22% |
| MLAB | $129.94 | -0.79% | 727.1M | 13.11 | $9.91 | +0.49% |
| QDEL | $10.54 | -0.52% | 718.7M | 7.87 | $1.34 | N/A |
| BWAY | $13.20 | -2.08% | 517.7M | 33.53 | $0.39 | N/A |
| MASS | $12.34 | +4.14% | 506.3M | -20.57 | -$0.60 | N/A |
| SI | $18.90 | +0.59% | 392M | -10.92 | -$1.73 | N/A |
| MOBI | $9.45 | +4.77% | 314.2M | -4.90 | -$1.93 | N/A |
| LAB | $0.74 | +3.83% | 289.9M | -10.58 | -$0.07 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
SKIN vs ALC Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, ALC has a market cap of 31.6B. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while ALC trades at $64.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas ALC's P/E ratio is 20.36. In terms of profitability, SKIN's ROE is -0.48%, compared to ALC's ROE of +0.03%. Regarding short-term risk, SKIN is more volatile compared to ALC. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check ALC's competition here
STERIS plc (NYSE: STE)
SKIN vs STE Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, STE has a market cap of 20.5B. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while STE trades at $210.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas STE's P/E ratio is 20.17. In terms of profitability, SKIN's ROE is -0.48%, compared to STE's ROE of +0.11%. Regarding short-term risk, SKIN is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check STE's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
SKIN vs MLAB Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, MLAB has a market cap of 727.1M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while MLAB trades at $129.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas MLAB's P/E ratio is 13.11. In terms of profitability, SKIN's ROE is -0.48%, compared to MLAB's ROE of +0.03%. Regarding short-term risk, SKIN is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check MLAB's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
SKIN vs QDEL Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, QDEL has a market cap of 718.7M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while QDEL trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas QDEL's P/E ratio is 7.87. In terms of profitability, SKIN's ROE is -0.48%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, SKIN is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check QDEL's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
SKIN vs BWAY Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, BWAY has a market cap of 517.7M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while BWAY trades at $13.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas BWAY's P/E ratio is 33.53. In terms of profitability, SKIN's ROE is -0.48%, compared to BWAY's ROE of +0.13%. Regarding short-term risk, SKIN is more volatile compared to BWAY. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check BWAY's competition here
908 Devices Inc. (NASDAQ: MASS)
SKIN vs MASS Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, MASS has a market cap of 506.3M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while MASS trades at $12.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas MASS's P/E ratio is -20.57. In terms of profitability, SKIN's ROE is -0.48%, compared to MASS's ROE of -0.25%. Regarding short-term risk, SKIN is more volatile compared to MASS. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
SKIN vs SI Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, SI has a market cap of 392M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while SI trades at $18.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas SI's P/E ratio is -10.92. In terms of profitability, SKIN's ROE is -0.48%, compared to SI's ROE of -0.26%. Regarding short-term risk, SKIN is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
SKIN vs MOBI Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, MOBI has a market cap of 314.2M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while MOBI trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas MOBI's P/E ratio is -4.90. In terms of profitability, SKIN's ROE is -0.48%, compared to MOBI's ROE of +0.80%. Regarding short-term risk, SKIN is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check MOBI's competition here
Standard BioTools Inc. (NASDAQ: LAB)
SKIN vs LAB Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, LAB has a market cap of 289.9M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while LAB trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas LAB's P/E ratio is -10.58. In terms of profitability, SKIN's ROE is -0.48%, compared to LAB's ROE of -0.18%. Regarding short-term risk, SKIN is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check LAB's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
SKIN vs ANIK Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, ANIK has a market cap of 263.1M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while ANIK trades at $19.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas ANIK's P/E ratio is 40.12. In terms of profitability, SKIN's ROE is -0.48%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SKIN is more volatile compared to ANIK. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check ANIK's competition here
Edap Tms S.a. (NASDAQ: EDAP)
SKIN vs EDAP Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas EDAP's P/E ratio is -5.80. In terms of profitability, SKIN's ROE is -0.48%, compared to EDAP's ROE of -3.13%. Regarding short-term risk, SKIN is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
SKIN vs NYXH Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, NYXH has a market cap of 138.1M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while NYXH trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas NYXH's P/E ratio is -0.55. In terms of profitability, SKIN's ROE is -0.48%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, SKIN is more volatile compared to NYXH. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check NYXH's competition here
Trinity Biotech plc (NASDAQ: TRIB)
SKIN vs TRIB Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, TRIB has a market cap of 130.2M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while TRIB trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas TRIB's P/E ratio is -0.11. In terms of profitability, SKIN's ROE is -0.48%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, SKIN is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check TRIB's competition here
Apyx Medical Corporation (NASDAQ: APYX)
SKIN vs APYX Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, APYX has a market cap of 105.5M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while APYX trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas APYX's P/E ratio is -12.52. In terms of profitability, SKIN's ROE is -0.48%, compared to APYX's ROE of -0.79%. Regarding short-term risk, SKIN is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check APYX's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
SKIN vs MDAI Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, MDAI has a market cap of 52.8M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while MDAI trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas MDAI's P/E ratio is -3.69. In terms of profitability, SKIN's ROE is -0.48%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, SKIN is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check MDAI's competition here
DarioHealth Corp. (NASDAQ: DRIO)
SKIN vs DRIO Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, DRIO has a market cap of 51.5M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while DRIO trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas DRIO's P/E ratio is -1.20. In terms of profitability, SKIN's ROE is -0.48%, compared to DRIO's ROE of +1.04%. Regarding short-term risk, SKIN is more volatile compared to DRIO. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check DRIO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
SKIN vs BEAT Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, BEAT has a market cap of 20.3M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while BEAT trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas BEAT's P/E ratio is -0.72. In terms of profitability, SKIN's ROE is -0.48%, compared to BEAT's ROE of -6.87%. Regarding short-term risk, SKIN is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check BEAT's competition here
Spectral AI, Inc. (NASDAQ: MDAIW)
SKIN vs MDAIW Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, MDAIW has a market cap of 15.1M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while MDAIW trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas MDAIW's P/E ratio is -1.34. In terms of profitability, SKIN's ROE is -0.48%, compared to MDAIW's ROE of N/A. Regarding short-term risk, SKIN is more volatile compared to MDAIW. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check MDAIW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SKIN vs BEATW Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, BEATW has a market cap of 4.3M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while BEATW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas BEATW's P/E ratio is -0.01. In terms of profitability, SKIN's ROE is -0.48%, compared to BEATW's ROE of -6.87%. Regarding short-term risk, SKIN is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check BEATW's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
SKIN vs WOK Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, WOK has a market cap of 4.3M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while WOK trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas WOK's P/E ratio is N/A. In terms of profitability, SKIN's ROE is -0.48%, compared to WOK's ROE of -0.19%. Regarding short-term risk, SKIN is more volatile compared to WOK. This indicates higher risk in terms of short-term price fluctuations for SKIN.Check WOK's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
SKIN vs QTEXW Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, SKIN's ROE is -0.48%, compared to QTEXW's ROE of N/A. Regarding short-term risk, SKIN is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
SKIN vs ITOC Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, ITOC has a market cap of 2.6M. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while ITOC trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas ITOC's P/E ratio is -0.90. In terms of profitability, SKIN's ROE is -0.48%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, SKIN is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check ITOC's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
SKIN vs FEED Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, FEED has a market cap of 798K. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while FEED trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas FEED's P/E ratio is -0.15. In terms of profitability, SKIN's ROE is -0.48%, compared to FEED's ROE of -0.60%. Regarding short-term risk, SKIN is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check FEED's competition here
Tivic Health Systems, Inc. (NASDAQ: TIVC)
SKIN vs TIVC Comparison October 2026
SkinHealth Systems Inc. (NASDAQ: SKIN) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SKIN stands at 81.6M. In comparison, TIVC has a market cap of 279.2K. Regarding current trading prices, SKIN is priced at $0.63 on the NASDAQ, while TIVC trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SKIN currently has a P/E ratio of -2.86, whereas TIVC's P/E ratio is -0.04. In terms of profitability, SKIN's ROE is -0.48%, compared to TIVC's ROE of -1.65%. Regarding short-term risk, SKIN is less volatile compared to TIVC. This indicates lower risk in terms of short-term price fluctuations for SKIN.Check TIVC's competition here